2017
DOI: 10.1016/j.atherosclerosis.2017.03.016
|View full text |Cite
|
Sign up to set email alerts
|

TRPV1 agonism inhibits endothelial cell inflammation via activation of eNOS/NO pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
65
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(67 citation statements)
references
References 33 publications
2
65
0
Order By: Relevance
“…57 On the other hand, PI3K/AKT/eNOS pathway is an important signaling pathway for ER stress, ROS production, inflammation and apoptosis in endothelial cells. [61][62][63][64] LY294002 had no effects on the functions of the HUVECs, which is consistent with previous findings. 65 We are speculating that the PI3K/AKT/eNOS signaling is activated by detrimental/protective stimulus, which can be effectively inhibited by LY294002; while at normal conditions, the PI3K/ATK/eNOS signaling may not be activated.…”
Section: Dovepresssupporting
confidence: 92%
“…57 On the other hand, PI3K/AKT/eNOS pathway is an important signaling pathway for ER stress, ROS production, inflammation and apoptosis in endothelial cells. [61][62][63][64] LY294002 had no effects on the functions of the HUVECs, which is consistent with previous findings. 65 We are speculating that the PI3K/AKT/eNOS signaling is activated by detrimental/protective stimulus, which can be effectively inhibited by LY294002; while at normal conditions, the PI3K/ATK/eNOS signaling may not be activated.…”
Section: Dovepresssupporting
confidence: 92%
“…Wang et al demonstrated that activating TRPV1 in endothelial cells could exert an antiinflammatory function characterized by a decrease in proinflammatory cytokine/chemokine production and adhesion molecule expression, as well as monocyte adhesion. This function may be due to the downregulation of NF-kB, a transcription factor modulating proinflammatory factor expression, by activation of TRPV1 via the Ca 2+ /PI3K/Akt/eNOS/ NO pathway [79]. The anti-inflammatory role of TRPV1 is also found in dendritic cells (DCs), a kind of immune cell presenting antigens to T cells and producing different cytokines to participate in immune-inflammatory responses.…”
Section: Trpv1 In Inflammatory Cellsmentioning
confidence: 99%
“…Regardless of how complicated the role of TRPV1 is in inflammation, the effects of TRPV1 directly on inflammatory cells and indirectly on inflammatory cells through these three neuropeptides seem to all involve NF-kB, a transcription factor associated with proinflammatory factors, such as TNF-α, IL-6, MCP-1, ICAM-1, and VCAM-1. The proinflammatory effects are mediated by their upregulation of NF-kB, whereas the anti-inflammatory roles are due to their downregulation of NF-kB [59,66,75,79]. However, a large number of studies are necessary to detail the role of the TRPV1/NF-kB signaling pathway in inflammation, especially in the progression of PAH.…”
Section: Trpv1 In Inflammatory Cellsmentioning
confidence: 99%
“…Nonivamide (pelargonic acid vanillylamide [PAVA]; C 17 H 27 NO 3 ), the phytochemical that is naturally found in hot peppers and oleoresin capsicum (Reilly, Crouch, Yost, & Fatah, 2002), is a less pungent capsaicin analogue that is similar to capsaicin in regard to chemical structure and pharmacological effects (Fang, Leu, Wang, & Tsai, 2002). PAVA is a transient receptor potential vanilloid 1 (TRPV1) agonist (Haas et al, 1997); the activation of TRPV1, which results in the suppression of the inflammatory response, also modulates metabolic pathways that improve cardiovascular health (Medina-Contreras et al, 2017;Wang et al, 2017). Moreover, PAVA has been shown to exert anti-obesity and antioxidant effects in addition to pain relief (Morales-Martínez et al, 2016;Srinivasan, 2016).…”
mentioning
confidence: 99%